Roivant Sciences Ltd. (ROIV) Stock Profile & Financial OverviewRoivant Sciences Ltd.
ROIV Company Overview & Business Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Key Information
Current Trend for ROIV
An assessment of the current trend environment for ROIV, based on the latest closing price data and intended to describe the market context heading into the next trading session.
As of 2025-12-24, the current trend for ROIV is an Indeterminate Transition Phase (Unclear Direction).
Daily and weekly trends are conflicting, reducing directional conviction and making directional trading less favorable at this stage.
- The weekly backdrop provides strong tailwinds, confirming that the medium-term path of least resistance is upward.
- Price is currently trending at a healthy distance, sitting 1.69 ATR away from the adaptive KAMA baseline.
- The market is maintaining a healthy 'Higher-High, Higher-Low' sequence, confirming buyer control.
Explore More Data
Adaptive Trend Model · Daily & Weekly (2025-12-24 ET)
This model uses an adaptive trend algorithm based on daily and weekly price data to identify whether a stock is in an uptrend, downtrend, or consolidation over a multi-week to multi-month horizon. Compared with traditional moving-average systems, it filters short-term noise more effectively, captures trend continuation more reliably, and provides a stronger basis for position sizing and risk-management decisions such as stop-loss and take-profit levels.
As of 2025-12-24, ROIV in a strong expansion phase; Long-term trend is bullish.
Trend Strength: ROIV last closed at 22.50, trading 1.2 ATR above the adaptive KAMA baseline (21.59). Technical Classification: Confirmed High-Momentum Uptrend.
Trend Score: Technical Score: 95/100. Classification: Strong/Established. Alignment: High. Logic: Full multi-timeframe alignment with strong momentum filters.
SuperTrend Risk: Structural Support: Adaptive SuperTrend at 19.10. This level serves as the calculated invalidation point for the current upward structure.
Risk Skew: Multi-timeframe risk skew is currently assessed as Constructive Upside. Daily and weekly trends are in high-quality alignment with healthy momentum. Risk skew favors continued upside follow-through from current levels.
Key Levels: In this bullish structure, key support is anchored by immediate support (KAMA) at 21.59, with the critical trend-guard (SuperTrend) at 19.10.